Fig. 3From: Nanotoxicological profiles of clinically approved nanoplatformsReproduced from Meng et al. [91], with permission from Elsevier (licence number 5373331323566)Schematic illustrations of naturally occurring and pathological barriers that can affect the fates of NPs in the body. Back to article page